Iterum Therapeutics PLC
NASDAQ:ITRM

Watchlist Manager
Iterum Therapeutics PLC Logo
Iterum Therapeutics PLC
NASDAQ:ITRM
Watchlist
Price: 0.945 USD 1.42% Market Closed
Market Cap: 32.7m USD

Relative Value

ITRM doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of ITRM.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ITRM Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.4
vs History
vs Industry
Median 3Y
-0.6
Median 5Y
-0.7
Industry
21
Forward
-0.8
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-0.9
Industry
16.2
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-0.8
Industry
24
vs History
vs Industry
11
Median 3Y
0.5
Median 5Y
0.5
Industry
2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.1
vs History
vs Industry
56
Median 3Y
-0.3
Median 5Y
-0.5
Industry
12.6
vs History
vs Industry
53
Median 3Y
-0.3
Median 5Y
-0.5
Industry
16
Forward
-2.6
vs History
vs Industry
56
Median 3Y
-0.3
Median 5Y
-0.5
Industry
14.4
vs History
vs Industry
44
Median 3Y
-0.3
Median 5Y
-0.5
Industry
17.6
vs History
44
vs Industry
29
Median 3Y
-0.8
Median 5Y
2.5
Industry
1.8

Multiples Across Competitors

ITRM Competitors Multiples
Iterum Therapeutics PLC Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
IE
Iterum Therapeutics PLC
NASDAQ:ITRM
33.7m USD 0 -1.5 -3.4 -3.3
US
Eli Lilly and Co
NYSE:LLY
687.3B USD 14 61.9 33.3 36.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
368.7B USD 4.1 16.9 12.4 16.2
DK
Novo Nordisk A/S
CSE:NOVO B
2.1T DKK 6.8 19.7 13.6 15.7
CH
Roche Holding AG
SIX:ROG
207.5B CHF 3.4 25.1 9.4 11
CH
Novartis AG
SIX:NOVN
183.5B CHF 4.2 17.3 10.2 13.7
UK
AstraZeneca PLC
LSE:AZN
162.6B GBP 4 28.3 130.8 197.2
US
Merck & Co Inc
NYSE:MRK
195.2B USD 3.1 11.2 8.4 10.1
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
134.2B USD 2.1 17 7.4 10.3
P/E Multiple
Earnings Growth PEG
IE
Iterum Therapeutics PLC
NASDAQ:ITRM
Average P/E: 24.7
Negative Multiple: -1.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
61.9
50%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
16.9
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
19.7
18%
1.1
CH
Roche Holding AG
SIX:ROG
25.1
32%
0.8
CH
Novartis AG
SIX:NOVN
17.3
17%
1
UK
AstraZeneca PLC
LSE:AZN
28.3
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.2
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
17
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IE
Iterum Therapeutics PLC
NASDAQ:ITRM
Average EV/EBITDA: 433.3
Negative Multiple: -3.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
33.3
30%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.4
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
13.6
13%
1
CH
Roche Holding AG
SIX:ROG
9.4
5%
1.9
CH
Novartis AG
SIX:NOVN
10.2
5%
2
UK
AstraZeneca PLC
LSE:AZN
130.8
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.4
8%
1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
2%
3.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IE
Iterum Therapeutics PLC
NASDAQ:ITRM
Average EV/EBIT: 1 866.8
Negative Multiple: -3.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.4
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.2
13%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
15.7
14%
1.1
CH
Roche Holding AG
SIX:ROG
11
6%
1.8
CH
Novartis AG
SIX:NOVN
13.7
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197.2
21%
9.4
US
Merck & Co Inc
NYSE:MRK
10.1
12%
0.8
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
10%
1